Trademark: 88221749
Status Date
Monday, January 4, 2021
Filing Date
Friday, December 7, 2018
Published for Opposition
Tuesday, April 7, 2020
Abandoned Date
Monday, January 4, 2021
5 Medical products and therapeutic applications for regenerative medicine, namely, human allograft tissue matrixes derived from amniotic membranes; human allograft tissue; biological tissue grafts; biological amniotic membrane tissue intended for injection for subsequent implantation; injectable medical products, namely, injectable flowable human amniotic membrane allograft; cryopreserved, flowable allograft tissue matrix derived from donated human amniotic membrane
Jan 4, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 4, 2021
Abandonment - No Use Statement Filed
Jun 2, 2020
Noa E-Mailed - Sou Required From Applicant
Apr 7, 2020
Official Gazette Publication Confirmation E-Mailed
Apr 7, 2020
Published For Opposition
Mar 18, 2020
Notification Of Notice Of Publication E-Mailed
Feb 28, 2020
Approved For Pub - Principal Register
Feb 5, 2020
Teas/Email Correspondence Entered
Feb 4, 2020
Correspondence Received In Law Office
Feb 4, 2020
Teas Response To Office Action Received
Aug 6, 2019
Notification Of Non-Final Action E-Mailed
Aug 6, 2019
Non-Final Action E-Mailed
Aug 6, 2019
Non-Final Action Written
Jul 10, 2019
Teas/Email Correspondence Entered
Jul 10, 2019
Correspondence Received In Law Office
Jul 3, 2019
Assigned To Lie
Jun 28, 2019
Teas Response To Office Action Received
Dec 31, 2018
Notification Of Non-Final Action E-Mailed
Dec 31, 2018
Non-Final Action E-Mailed
Dec 31, 2018
Non-Final Action Written
Dec 31, 2018
Assigned To Examiner
Dec 31, 2018
New Application Office Supplied Data Entered In Tram
Dec 11, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
